Biopharmaceutical characterization of nebulized antimicrobial agents in rats. 4. aztreonam

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 5, 2016, Pages 3196-3198

  Marchand, Sandrine ^a,b,c   Grégoire, Nicolas ^a,b   Brillault, Julien ^a,b   Lamarche, Isabelle ^a,b   Gobin, Patrice ^a,c   Couet, William ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM;

ANIMAL; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZTREONAM; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84964892315     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00165-16     Document Type: Article

References (10)

1. Flume PA, VanDevanter DR. 2015. Clinical applications of pulmonary delivery of antibiotics. Adv Drug Deliv Rev 85:1-6. http://dx.doi.org/10.1016/j.addr.2014.10.009.
2. Falagas ME, Trigkidis KK, Vardakas KZ. 2015. Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: a systematic review. Int J Antimicrob Agents 45:221-233. http://dx.doi.org/10.1016/j.ijantimicag.2014.10.008.
3. Marchand S, Gregoire N, Brillault J, Lamarche I, Gobin P, Couet W. 2015. Biopharmaceutical characterization of nebulized antimicrobial agents in rats. 3. Tobramycin. Antimicrob Agents Chemother 59:6646-6647. http://dx.doi.org/10.1128/AAC.01647-15.
4. Gontijo AV, Gregoire N, Lamarche I, Gobin P, Couet W, Marchand S. 2014. Biopharmaceutical characterization of nebulized antimicrobial agents in rats. 2. Colistin. Antimicrob Agents Chemother 58:3950-3956. http://dx.doi.org/10.1128/AAC.02819-14.
5. Brillault J, De Castro WV, Harnois T, Kitzis A, Olivier JC, Couet W. 2009. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. Antimicrob Agents Chemother 53:1457-1462. http://dx.doi.org/10.1128/AAC.01253-08.
6. Brillault J, De Castro WV, Couet W. 2010. Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model. Antimicrob Agents Chemother 54:543-545. http://dx.doi.org/10.1128/AAC.00733-09.
7. Marchand S, Gobin P, Brillault J, Baptista S, Adier C, Olivier JC, Mimoz O, Couet W. 2010. Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats. Antimicrob Agents Chemother 54:3702-3707. http://dx.doi.org/10.1128/AAC.00411-10.
8. Bulitta JB, Bingolbali A, Shin BS, Landersdorfer CB. 2011. Development of a new pre- and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT. AAPS J 13:201-211. http://dx.doi.org/10.1208/s12248-011-9257-x.
9. Vinks AA, van Rossem RN, Mathot RA, Heijerman HG, Mouton JW. 2007. Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using Monte Carlo simulation. Antimicrob Agents Chemother 51:3049-3055. http://dx.doi.org/10.1128/AAC.01522-06.
10. Gontijo AV, Brillault J, Gregoire N, Lamarche I, Gobin P, Couet W, Marchand S. 2014. Biopharmaceutical characterization of nebulized antimicrobial agents in rats. 1. Ciprofloxacin, moxifloxacin and grepafloxacin. Antimicrob Agents Chemother 58:3942-3949. http://dx.doi.org/10.1128/AAC.02818-14.